October 31, 2024

---

Evogene announces collaboration with Google Cloud to pioneer generative AI foundation model for novel small molecule design

August 23, 2024

---

Evogene announces pricing of US$5.5 million registered direct offering and concurrent private placement

August 22, 2024

---

Evogene reports second quarter 2024 financial results

July 17, 2024

---

ICL and Lavie Bio leverage artificial intelligence to make significant advancement in the development of yield increasing bio-stimulants

July 2, 2024

---

Lavie Bio announces commercial expansion of its bio-inoculant product, Yalos, to winter wheat

June 25, 2024

---

Casterra Ag announces an additional purchase order to supply castor seeds to a new African country

May 23, 2024

---

Evogene reports first quarter 2024 financial results

April 2, 2024

---

Evogene and The Kitchen FoodTech Hub by Strauss Group established Finally Foods Ltd. – Revolutionizing protein production in plants for the food industry

March 19, 2024

---

Bayer AG and Lavie Bio continue for second year of biofungicides validation following successful lab and greenhouse testing

March 7, 2024

---

Evogene reports fourth quarter and full year 2023 financial results

December 19, 2023

---

Casterra appoints new CEO and expands team to drive growth and innovation

November 16, 2023

---

Evogene reports third quarter 2023 financial results

October 18, 2023

---

Evogene provides operational update amidst current security situation in Israel

September 27, 2023

---

Casterra delivers first shipment of castor seeds to Africa

August 17, 2023

---

Evogene reports second quarter 2023 financial results

July 25, 2023

---

Evogene’s ChemPass AI tech-engine is introduced with new breakthrough machine learning technology for target-protein discovery

July 17, 2023

---

Evogene announces pricing of US$8,500,000 registered direct offering

Lavie Bio announces licensing agreement for bio-fungicides with Corteva Agriscience - Corteva to receive exclusive rights to further develop and commercialize Lavie Bio’s lead product candidates for fruit rot and powdery mildew fungicide biologicals

July 7, 2023

---

Evogene's subsidiary Casterra: $11.3M sale of castor plant seeds may be the tip of the iceberg (Seeking Alpha)

July 4, 2023

---

Casterra announces additional $2.2 million of purchase orders to supply castor seeds for new African territories

May 24, 2023

---

Lavie Bio receives Canadian regulatory approval for its bio-inoculant seed treatment Thrivus, expanding global reach

May 18, 2023

---

Evogene reports first quarter 2023 financial results

May 9, 2023

---

Evogene's ag-seed division awarded prestigious €1.2M Horizon grant to develop oilseed crops with high CO2 assimilation and drought tolerance

March 9, 2023

---

Evogene reports fourth quarter and full year 2022 financial results

January 19, 2023

---

Casterra announces agreement with world leading energy company to cultivate its castor varieties at commercial scale

December 8, 2022

---

Evogene to receive $3.5 million payment related to patent portfolio under its existing seed traits collaboration with Bayer

November 18, 2022

---

Evogene reports third quarter 2022 financial results

October 12, 2022

---

Lavie Bio advances its novel bio-fungicide program and applies to the U.S. EPA for regulatory approval - LAV.311 is targeting fruit rots and powdery mildews fungal diseases

August 31, 2022

---

Evogene reports second quarter 2022 financial results

August 18, 2022

---

ICL and Lavie Bio enter strategic collaboration to develop novel bio-stimulant products